The 9th MD Anderson Cancer Center International Meeting In Gynecologic Oncology will be held from October 24-25th, 2024 at Madrid, Spain. The 9th MD Anderson Cancer Center International Meeting in Gynecologic Oncology will focus on the latest advancements in gynecologic cancer treatment, research, and care. Bringing together experts from around the world, the meeting will […]

SOHO Spain 2025 will be held from February 27-28, 2025 at Madrid, Spain. The SOHO Spain 2025 conference, organized by the Society of Hematologic Oncology (SOHO), is a global event dedicated to clinicians, research scientists, and healthcare professionals specializing in the research and treatment of hematologic malignancies. Established in 2012, SOHO’s mission is to accelerate […]

2025 Hematopoietic Stem Cell and Myelodysplastic Syndromes (MDS) Symposium will be held from May 21-22, 2025 at Houston, Texas. The 2025 Hematopoietic Stem Cell and Myelodysplastic Syndromes (MDS) Symposium will bring together global experts to explore the latest advancements in MDS research and treatment. This event focuses on the biological mechanisms of hematopoietic stem cells […]

The 22nd Oncology Updates: Advanced and Controversies Conference, presented by The University of Texas MD Anderson Cancer Center, is an interactive, multidisciplinary forum held from Friday, January 16 to Monday, January 19, 2026, at the Steamboat Grand Hotel in Steamboat Springs, Colorado. The conference is designed to address the rapidly evolving complexities of solid tumor […]

The 2026 Oncologic Emergency Medicine Conference, hosted by The University of Texas MD Anderson Cancer Center, is a hybrid event taking place Friday, February 6, to Saturday, February 7, 2026. The in-person portion will be held at the MD Anderson - Duncan Building (1155 Pressler Street) in Houston, Texas, and will also be streamed virtually. […]

The 2026 International Cancer Neuroscience Symposium, hosted by The University of Texas MD Anderson Cancer Center Cancer Neuroscience Program and Wiley's Advanced Portfolio, is a three-day dynamic hybrid event scheduled for Wednesday, February 18, to Friday, February 20, 2026. The in-person component will be held at the TMC3 Collaborative Building in Houston, Texas. This biennial […]

The Colorectal Liver Metastasis Consensus Conference, based on the Danish-Zurich model, is a three-day in-person conference dedicated to advancing care, research, and building consensus for the treatment of colorectal liver metastases. Scheduled from Tuesday, February 24, to Thursday, February 26, 2026, the meeting will be held at the TMC3 Collaborative Building (7255 Helix Park Ave.) […]

The Updates on Advanced Breast Cancer: Local Management and Other New Perspectives conference is a one-and-a-half-day, in-person event scheduled for February 27–28, 2026, at the Houston Marriott Medical Center in Houston, TX. Hosted by The University of Texas MD Anderson Cancer Center, the activity's main goal is to emphasize the integration of novel therapies and […]

The 2026 IOTOX Symposium: Delivering What Matters - Patient-Centered through IOTOX Translational Science, organized by The University of Texas MD Anderson Cancer Center, is a hybrid educational event scheduled from Friday, April 24, to Saturday, April 25, 2026. This symposium is dedicated to bridging the gap between translational science and clinical practice, offering healthcare professionals […]

The ALIGN 2026: Advancing Learning and Innovation in Goal Concordant Care conference is an interdisciplinary scientific meeting scheduled for April 29–30, 2026, in Houston, Texas. Organized by The University of Texas MD Anderson Cancer Center, the symposium focuses on optimizing oncological care by aligning medical treatments with individual patient values, preferences, and goals. The program […]